Cue Biopharma/$CUE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cue Biopharma
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
Ticker
$CUE
Sector
Primary listing
Employees
29
Headquarters
Website
Cue Biopharma Metrics
BasicAdvanced
$87m
-
-$5.22
-
-
Price and volume
Market cap
$87m
52-week high
$41.42
52-week low
$10.76
Average daily volume
142k
Financial strength
Current ratio
3.571
Quick ratio
3.341
Long term debt to equity
8.691
Total debt to equity
15.92
Interest coverage (TTM)
-84.06%
Profitability
EBITDA (TTM)
-18.162
Gross margin (TTM)
-6.45%
Net profit margin (TTM)
-59.65%
Operating margin (TTM)
-59.84%
Effective tax rate (TTM)
-2.63%
Revenue per employee (TTM)
$1,130,000
Management effectiveness
Return on assets (TTM)
-46.08%
Return on equity (TTM)
-138.52%
Valuation
Price to revenue (TTM)
3.055
Price to book
4.03
Price to tangible book (TTM)
4.03
Price to free cash flow (TTM)
-4.064
Free cash flow yield (TTM)
-24.61%
Free cash flow per share (TTM)
-6.577
Growth
Revenue change (TTM)
309.60%
Earnings per share change (TTM)
-73.17%
3-year revenue growth (CAGR)
323.15%
3-year earnings per share growth (CAGR)
-49.37%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs